Health articles

Novartis, Medicines for Malaria Venture launch a novel compound against multidrug-resistant malaria

Ahead of the World Malaria Day, Novartis and Medicines for Malaria Venture (MMV) have launched a patient trial for KAF156, a next-generation antimalarial compound with the potential to treat drug-resistant strains of the malaria parasite. The trial will test the efficacy of KAF156 in combination with a new, improved formulation of the existing antimalarial lumefantrine.

GAVI warns that vaccine progress in developing countries ‘in danger of stalling

New WHO/UNICEF figures released this week show that in 68 of the world’s poorest countries, while close to a million more children received the basic diphtheria-tetanus-pertussis vaccine in 2016 compared to 2015, the coverage rate has remained at 80% for the past three years. Millions of children remain under-vaccinated in countries torn apart by conflict,

UN-backed initiative greatly improves the health of women, children, adolescents

A new report developed by the Partnership for Maternal, Newborn & Child Health (PMNCH), a coalition of more than 800 organizations, and the show that the health and well-being of women, children and adolescents are improving faster than at any point in history, even in the poorest nations The transformation is due in great measure

Kenya unveils better HIV/AIDS treatment

By George Okore Kenya has become the first African country in Africa to offer a new first-line drug for people living with HIV, thus accelerating access to better antiretroviral (ARV) drugs The debut of generic version of Dolutegravir (DTG) is a relief people living with HIV in Africa, where it’s needed most. Today’s launch also

Kenya introduces better treatment for people living with HIV

Herman Opndo The Government of Kenya and Unitaid announced Wednesday in Nairobi the introduction of Dolutegravir (DTG), a new first-line drug for people living with HIV, making Kenya the first African country to introduce the generic version of this new drug for routine use. Dolutegravir (DTG) has been the drug of choice for the last

Dr Tedros Adhanom Ghebreyesus, an Ethiopian is New Who Director-General

The WHO has Tuesday elected elected Dr Tedros Adhanom Ghebreyesus, an Ethiopian, as its new Director-General. He will succeed Dr Margaret Chan, who has been WHO’s Director-General since 1 January 2007. Prior to his election as WHO’s next Director-General, Dr Tedros Adhanom Ghebreyesus served as Minister of Foreign Affairs, Ethiopia from 2012-2016 and as Minister

Top